
Overview
Kelvin L. Chou, M.D. is a Clinical Professor in the Departments of Neurology and Neurosurgery at Michigan Medicine and was the inaugural Thomas H. and Susan C. Brown Early Career Professor in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and sees all patients with movement disorders (i.e. Parkinson’s disease, tremors, dystonia, Huntington disease), though he has a particular interest in Parkinson’s disease (PD) and deep brain stimulation (DBS). Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program and his research focus is on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He directs the Neurology Clinical Trials Organization (NeCTO) and is Lead Medical Director of the Neuroscience and Sensory Clinical Trials Support Unit (CTSU) at Michigan Medicine. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders. A strong patient advocate, Dr. Chou is the Education and Outreach Core Director for the U-M Udall Center of Excellence for PD Research and serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor.
Dr. Chou is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation.
Dr. Chou is board certified in Neurology. He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 4 clinical trials. Dr. Chou is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- HMO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4260 Plymouth Rd, Level 1, Ann Arbor, MI 48109
1500 E Medical Center Dr, Floor 1 Reception C, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Chou has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
East Ann Arbor Health & Geriatrics Center
Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology. Dr. Paulson is currently accepting new patients.
Regents Of The Univ. Of Michigan
Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.
East Ann Arbor Health & Geriatrics Center
Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology. Dr. Albin is currently accepting new patients.
Taubman Center
Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is highly rated in 34 conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Primary Lateral Sclerosis. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine. Dr. Feldman is currently accepting new patients.
East Ann Arbor Health & Geriatrics Center
Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Todd is board certified in Neurology. Dr. Todd is currently accepting new patients.
U Of M Radiology Nuclear Medicine
Nicolaas Bohnen is a Nuclear Medicine specialist and a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Bohnen is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Osteopenia, Melorheostosis, and Deep Brain Stimulation. Dr. Bohnen is currently accepting new patients.
Frequently Asked Questions about Dr. Kelvin L. Chou
How do I make an appointment with Dr. Kelvin L. Chou?
You can book an appointment with Dr. Kelvin L. Chou by calling their office at 734-764-6831. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kelvin L. Chou a top-rated expert for Parkinson's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kelvin L. Chou is classified as an Elite expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kelvin L. Chou specialize in?
While Dr. Kelvin L. Chou is a Neurology, they have specific expertise in Parkinson's Disease, Movement Disorders, and Essential Tremor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Kelvin L. Chou participate in research or clinical trials?
Yes. Dr. Kelvin L. Chou has published 95 articles and abstracts on conditions like Parkinson's Disease. You can view a list of Dr. Kelvin L. Chou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kelvin L. Chou accept my insurance?
Dr. Kelvin L. Chou accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-764-6831 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Movement DisordersDr. Chou isElite. Learn about Movement Disorders.
- Parkinson's DiseaseDr. Chou isElite. Learn about Parkinson's Disease.
- Distinguished
- Deep Brain StimulationDr. Chou isDistinguished. Learn about Deep Brain Stimulation.
- Drug Induced DyskinesiaDr. Chou isDistinguished. Learn about Drug Induced Dyskinesia.
- DysarthriaDr. Chou isDistinguished. Learn about Dysarthria.
- Essential TremorDr. Chou isDistinguished. Learn about Essential Tremor.
- Focal DystoniaDr. Chou isDistinguished. Learn about Focal Dystonia.
- Advanced
- ChoreaDr. Chou isAdvanced. Learn about Chorea.
- Dry MouthDr. Chou isAdvanced. Learn about Dry Mouth.
- Huntington DiseaseDr. Chou isAdvanced. Learn about Huntington Disease.
- Lewy Body Dementia (LBD)Dr. Chou isAdvanced. Learn about Lewy Body Dementia (LBD).
- Mcleod Neuroacanthocytosis Syndrome
- Myoclonus-DystoniaDr. Chou isAdvanced. Learn about Myoclonus-Dystonia.
- Oppenheim DystoniaDr. Chou isAdvanced. Learn about Oppenheim Dystonia.
- Opsoclonus-Myoclonus SyndromeDr. Chou isAdvanced. Learn about Opsoclonus-Myoclonus Syndrome.
- Orthostatic HypotensionDr. Chou isAdvanced. Learn about Orthostatic Hypotension.
- Primary Orthostatic TremorDr. Chou isAdvanced. Learn about Primary Orthostatic Tremor.
- Progressive Supranuclear Palsy
- Progressive Supranuclear Palsy Atypical
- REM Behavior DisorderDr. Chou isAdvanced. Learn about REM Behavior Disorder.
- Secondary ParkinsonismDr. Chou isAdvanced. Learn about Secondary Parkinsonism.
- Serotonin SyndromeDr. Chou isAdvanced. Learn about Serotonin Syndrome.
- Supranuclear Ocular PalsyDr. Chou isAdvanced. Learn about Supranuclear Ocular Palsy.
- Supranuclear OphthalmoplegiaDr. Chou isAdvanced. Learn about Supranuclear Ophthalmoplegia.
- X-Linked Dystonia-Parkinsonism
- Experienced
- ApraxiaDr. Chou isExperienced. Learn about Apraxia.
- Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
- AthetosisDr. Chou isExperienced. Learn about Athetosis.
- CamptocormismDr. Chou isExperienced. Learn about Camptocormism.
- Cerebellar DegenerationDr. Chou isExperienced. Learn about Cerebellar Degeneration.
- Cerebellar Multiple System AtrophyDr. Chou isExperienced. Learn about Cerebellar Multiple System Atrophy.
- Congenital Cardiovascular ShuntDr. Chou isExperienced. Learn about Congenital Cardiovascular Shunt.
- Conversion DisorderDr. Chou isExperienced. Learn about Conversion Disorder.
- Corticobasal DegenerationDr. Chou isExperienced. Learn about Corticobasal Degeneration.
- DementiaDr. Chou isExperienced. Learn about Dementia.
- Developmental Dysphasia FamilialDr. Chou isExperienced. Learn about Developmental Dysphasia Familial.
- Dopa-Responsive DystoniaDr. Chou isExperienced. Learn about Dopa-Responsive Dystonia.
- EpilepsyDr. Chou isExperienced. Learn about Epilepsy.
- Familial Benign Copper DeficiencyDr. Chou isExperienced. Learn about Familial Benign Copper Deficiency.
- Familial DysautonomiaDr. Chou isExperienced. Learn about Familial Dysautonomia.
- Familial Paroxysmal Nonkinesigenic Dyskinesia
- Generalized Tonic-Clonic SeizureDr. Chou isExperienced. Learn about Generalized Tonic-Clonic Seizure.
- InsomniaDr. Chou isExperienced. Learn about Insomnia.
- Low Blood PressureDr. Chou isExperienced. Learn about Low Blood Pressure.
- Meige SyndromeDr. Chou isExperienced. Learn about Meige Syndrome.
- Memory LossDr. Chou isExperienced. Learn about Memory Loss.
- Menkes DiseaseDr. Chou isExperienced. Learn about Menkes Disease.
- Multiple System AtrophyDr. Chou isExperienced. Learn about Multiple System Atrophy.
- Neurotoxicity SyndromesDr. Chou isExperienced. Learn about Neurotoxicity Syndromes.
- Normal Pressure HydrocephalusDr. Chou isExperienced. Learn about Normal Pressure Hydrocephalus.
- Peripheral NeuropathyDr. Chou isExperienced. Learn about Peripheral Neuropathy.
- Restless Legs SyndromeDr. Chou isExperienced. Learn about Restless Legs Syndrome.
- SeizuresDr. Chou isExperienced. Learn about Seizures.
- ShinglesDr. Chou isExperienced. Learn about Shingles.
- Tardive DyskinesiaDr. Chou isExperienced. Learn about Tardive Dyskinesia.
- Tourette SyndromeDr. Chou isExperienced. Learn about Tourette Syndrome.
- Wilson DiseaseDr. Chou isExperienced. Learn about Wilson Disease.




